Latest cancer detection Stories
Addition of tomosynthesis increased breast cancer detection and simultaneously reduced recall rates BEDFORD, Mass., May 1, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products with an emphasis on serving the healthcare needs of women, today announced the publication of the final results of a large-scale prospective study comparing breast cancer...
May improve detection in dense breasts 2D plus 3D breast imaging increases cancer detection rates by 11%, and could be particularly useful in detecting cancer in women with dense breasts, a new study suggests. Researchers at Yale University Smilow Cancer Hospital in New Haven, CT, reviewed the screening mammograms of 14,684 patients. Forty-two cancers were found in 8,769 patients who had only 2D imaging (a cancer detection rate of 4.8 per 1,000), said Dr. Jaime Geisel, a lead author of...
TALLAHASSEE, Fla., Feb. 14, 2013 /PRNewswire/ -- Today, the findings of the largest reported study on prostate biopsies were released at the American Society of Clinical Oncology Genitourinary Cancers Symposium in Orlando. The research confirmed that cancer detection rates are enhanced when 10 to 12-specimens are obtained during the biopsy. "The study, which included over 4.2 million specimens collected from nearly 440,000 biopsies, confirms that biopsy regimens with 10 to 12...
BEDFORD, Mass., Jan. 9, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that a groundbreaking new study published in Radiology, the Radiological Society of North America scientific journal, found that the addition of three dimensional (3D) mammography (breast tomosynthesis)...
MicroRNA molecules potential biomarkers for early cancer detection, reports cancer biomarkers As many as 50 percent of all human protein-coding genes are regulated by microRNA (miRNA) molecules. While some miRNAs impact onset and progression of cancer, others can actually suppress the development of malignant tumors and are useful in cancer therapy. They can also serve as potential biomarkers for early cancer detection. In a new issue of Cancer Biomarkers, investigators report on...
BREA, Calif., June 25, 2012 /PRNewswire/ -- Beckman Coulter, Inc., the leader in prostate cancer diagnostics, announces Premarket Approval (PMA) from the U.S. Food and Drug Administration (FDA) for the Prostate Health Index (phi), a simple, non-invasive blood test that is 2.5-times more specific in detecting prostate cancer[1] than PSA (prostate-specific antigen) in patients with PSA values in the 4-10 ng/mL range and is proven to reduce the number of prostate biopsies[2]. (Photo:...
The addition of a screening ultrasound or magnetic resonance imaging (MRI) to annual mammography in women with an increased risk of breast cancer and dense breast tissue resulted in a higher rate of detection of incident breast cancers, according to a study in the April 4 issue of JAMA. "Annual ultrasound screening may detect small, node-negative breast cancers that are not seen on mammography. Magnetic resonance imaging may reveal additional breast cancers missed by both mammography and...
NEWPORT NEWS, Va., March 27, 2012 /PRNewswire/ -- Dilon Diagnostics -- According to the results from a new multi-center patient registry, presented at the National Consortium of Breast Centers Annual Meeting on March 11th, 2012, Breast-Specific Gamma Imaging (BSGI) also known as Molecular Breast Imaging (MBI) improves breast cancer detection when added to mammography and ultrasound in the breast clinic. In this study, BSGI/MBI detected cancers in nearly 13% of patients with negative...
90 percent detection rate in clinical tests for multiple types of cancers A simple blood test is being developed by researchers at Ben-Gurion University of the Negev (BGU) and Soroka University Medical Center in Beer-Sheva, Israel that may provide early detection of many types of cancer. Prof. Kapelushnik of BGU's Faculty of Health Sciences and his team developed a device that illuminates cancer cells with less than a teaspoon of blood. The test uses infrared light to detect miniscule...
MammaCare technology sets standards for clinical breast exams MammaCare, a revolutionary tool that has set standards for teaching women and clinicians how to perform clinical breast exams, is training professionals around the country to detect lumps earlier and save lives. Widely-publicized statistics inform women about the importance of early detection of cancer. The Center for Disease Control reports that second only to skin cancer, breast cancer is the most common cancer among...
